These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 29323627

  • 1. A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 g for the Treatment of Women and Postmenarchal Adolescent Girls with Bacterial Vaginosis.
    Chavoustie SE, Gersten JK, Samuel MJ, Schwebke JR.
    J Womens Health (Larchmt); 2018 Apr; 27(4):492-497. PubMed ID: 29323627
    [Abstract] [Full Text] [Related]

  • 2. A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis.
    Schwebke JR, Morgan FG, Koltun W, Nyirjesy P.
    Am J Obstet Gynecol; 2017 Dec; 217(6):678.e1-678.e9. PubMed ID: 28867602
    [Abstract] [Full Text] [Related]

  • 3. Secnidazole Treatment of Bacterial Vaginosis: A Randomized Controlled Trial.
    Hillier SL, Nyirjesy P, Waldbaum AS, Schwebke JR, Morgan FG, Adetoro NA, Braun CJ.
    Obstet Gynecol; 2017 Aug; 130(2):379-386. PubMed ID: 28697102
    [Abstract] [Full Text] [Related]

  • 4. Secnidazole for treatment of bacterial vaginosis: a systematic review.
    Abd El Aziz MA, Sharifipour F, Abedi P, Jahanfar S, Judge HM.
    BMC Womens Health; 2019 Oct 21; 19(1):121. PubMed ID: 31638955
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of single dose of oral secnidazole 2 g in treatment of bacterial vaginosis: A systematic review and meta-analysis.
    Elghazaly SM, Hamam KM, Badawy MM, Yakoub Agha NA, Samy A, Abbas AM.
    Eur J Obstet Gynecol Reprod Biol; 2019 Jul 21; 238():125-131. PubMed ID: 31129560
    [Abstract] [Full Text] [Related]

  • 6. Low-dose secnidazole in the treatment of bacterial vaginosis.
    Núñez JT, Gómez G.
    Int J Gynaecol Obstet; 2005 Mar 21; 88(3):281-5. PubMed ID: 15733882
    [Abstract] [Full Text] [Related]

  • 7. An Integrated Efficacy and Safety Analysis of Single-Dose Secnidazole 2 g in the Treatment of Bacterial Vaginosis.
    Pentikis H, Adetoro N, Tipping D, Levy S.
    Reprod Sci; 2020 Feb 21; 27(2):523-528. PubMed ID: 32046418
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of bacterial vaginosis: a multicenter, double-blind, double-dummy, randomised phase III study comparing secnidazole and metronidazole.
    Bohbot JM, Vicaut E, Fagnen D, Brauman M.
    Infect Dis Obstet Gynecol; 2010 Feb 21; 2010():. PubMed ID: 20885970
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Secnidazole: next-generation antimicrobial agent for bacterial vaginosis treatment.
    Nyirjesy P, Schwebke JR.
    Future Microbiol; 2018 Apr 21; 13():507-524. PubMed ID: 29327947
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study.
    Muzny CA, Schwebke JR, Nyirjesy P, Kaufman G, Mena LA, Lazenby GB, Van Gerwen OT, Graves KJ, Arbuckle J, Carter BA, McMahon CP, Eder S, Shaw J, Pandey B, Chavoustie SE.
    Clin Infect Dis; 2021 Sep 15; 73(6):e1282-e1289. PubMed ID: 33768237
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy of 5-nitroimidazole derivatives in treatment of bacterial vaginosis].
    Wang FM, Qian XD, Xu H, Yu HY.
    Zhonghua Yi Xue Za Zhi; 2008 Aug 12; 88(31):2201-3. PubMed ID: 19080672
    [Abstract] [Full Text] [Related]

  • 15. Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis.
    Gillis JC, Wiseman LR.
    Drugs; 1996 Apr 12; 51(4):621-38. PubMed ID: 8706597
    [Abstract] [Full Text] [Related]

  • 16. Treatment considerations for bacterial vaginosis and the risk of recurrence.
    Chen JY, Tian H, Beigi RH.
    J Womens Health (Larchmt); 2009 Dec 12; 18(12):1997-2004. PubMed ID: 20044862
    [Abstract] [Full Text] [Related]

  • 17. Lack of a Pharmacokinetic Interaction Between SYM-1219 Granules Containing 2 Grams of Secnidazole and a Combined Oral Contraceptive in a Phase 1, Randomized, Open-Label Study in Healthy Female Volunteers.
    Pentikis HS, Adetoro N, Braun CJ.
    Adv Ther; 2017 Jan 12; 33(12):2229-2241. PubMed ID: 27744624
    [Abstract] [Full Text] [Related]

  • 18. Thorough QT/QTc Evaluation of the Cardiac Safety of Secnidazole at Therapeutic and Supratherapeutic Doses in Healthy Individuals.
    Darpo B, Xue H, Adetoro N, Matthews BG, Pentikis HS.
    J Clin Pharmacol; 2018 Mar 12; 58(3):286-293. PubMed ID: 28967984
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of single-dose oral secnidazole for the treatment of trichomoniasis in women co-infected with trichomoniasis and bacterial vaginosis: a post hoc subgroup analysis of phase 3 clinical trial data.
    Muzny CA, Van Gerwen OT, Kaufman G, Chavoustie S.
    BMJ Open; 2023 Aug 07; 13(8):e072071. PubMed ID: 37550019
    [Abstract] [Full Text] [Related]

  • 20. Characterization and Treatment of Recurrent Bacterial Vaginosis.
    Faught BM, Reyes S.
    J Womens Health (Larchmt); 2019 Sep 07; 28(9):1218-1226. PubMed ID: 31403349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.